[18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies

Authors :: Søren Hess
Ties Mulders
Marnix G.E.H. Lam
Maarten L. Donswijk
Source :: Donswijk, M, Hess, S, Mulder, T & MGEH, L 2014, ' [ 18 F]fluorodeoxyglucose PET/computed tomography in gastrointestinal malignancies ', P E T Clinics, vol. 9, no. 4, pp. 421-441 . https://doi.org/10.1016/j.cpet.2014.07.001
Publication Year :: 2015
Abstract: This article discusses the current state-of-the-Art application of 2-deoxy-2-[ 18F]fluoro-d-glucose (FDG)-PET and FDG-PET/computed tomography (CT) in the management of patients with gastrointestinal malignancies. Gastrointestinal malignancies include many different cell types, several common malignancies of which may be imaged by FDG-PET/CT. This review focuses on gastric carcinoma, pancreatic carcinoma, hepatocellular carcinoma, cholangiocarcinoma, colorectal carcinoma, and stroma cell tumors. The role of FDG-PET/CT in staging these malignancies is discussed, in addition to (re)staging, detection of recurrent disease, patient selection/prognostication, and response assessment, using the currently available literature.

Tools